For the second straight year the Children’s Tumor Foundation, the leading non-government funding source of neurofibromatosis (NF) research, has been awarded a four star (highest) rating by Charity Navigator, America’s largest independent charity evaluator. Only 19% of charities reviewed by Charity Navigator have received at least two consecutive four star evaluations.
“Children’s Tumor Foundation consistently executes its mission in a fiscally responsible way, and outperforms most other charities in America,” wrote Ken Berger, President and CEO of Charity Navigator. “This ‘exceptional’ designation from Charity Navigator differentiates Children’s Tumor Foundation from its peers and demonstrates to the public it is worthy of their trust.”
“We are committed to ensuring that every dollar raised is put to the very best use to improve the lives of those living with NF1, NF2, and schwannomatosis,” said George Orfanakos, President of the Children’s Tumor Foundation. “From the transparency of our financial reporting [cited in the New York Times], to the success of our research programs in receiving follow-on funding — which further amplifies our donors’ support — that commitment is demonstrable. We are honored that Charity Navigator has once again recognized it.”
The annual rating, which Charity Navigator uses to meet its mission of guiding “intelligent giving,” is based on two broad areas: organizational efficiency and organizational capacity, or, how responsibly a charity functions day to day, and how well positioned it is to sustain its programs over time. The charity is then awarded an overall rating, ranging from zero to four stars, with four stars being the highest rating.
To view the Children’s Tumor Foundation’s Charity Navigator page please click here.
To view the letter acknowledging the Foundation’s rating please click here (pdf).
